SARS IN CHILDREN. POSSIBLE SOLUTIONS OF THE PROBLEM
This article is the analytical review of clinical studies results of the efficacy and safety of Kagocel® in ARVI (acute respiratory viral infection) and other viral infections treatment in children. Studies, innovations and initiatives in the searching of prevention and effective drugs against influenza and other pathogens of acute respiratory viral infections (ARVI) is very important. The course of acute respiratory viral infections and influenza in children is accompanied in most cases by symptoms of intoxication and frequent complications. The conclusions about the effectiveness and reasonability of Kagocel® for treatment and preventing of ARVI in children are made.